Orii Fumika, Ashida Toshifumi, Nomura Masafumi, Maemoto Atsuo, Fujiki Takanori, Ayabe Tokiyoshi, Imai Shinjiro, Saitoh Yusuke, Kohgo Yutaka
Third Department of Internal Medicine, Asahikawa Medical College, 2-1 Midorigaoka-higashi, Hokkaido 078-8510, Asahikawa, Japan.
Biochem Biophys Res Commun. 2002 Sep 6;296(5):1286-94. doi: 10.1016/s0006-291x(02)02030-2.
We have previously reported that in peripheral blood mononuclear cells (PBMC), the augmented expression of the beta isoform of the human glucocorticoid receptor (hGRbeta), as a putative dominant negative regulator of glucocorticoid action, is associated with glucocorticoid (GC) unresponsiveness of UC patients. In this study, we quantified the levels and serial changes of hGR transcripts in PBMC of IBD patients by a real-time fluorescence monitoring of PCR. As results, relative hGRbeta mRNA expression was significantly higher in the active stage of UC than in inactive periods of UC or CD patients. Longitudinal analysis revealed that hGRbeta mRNA expression in UC was increased after the relapse of inflammation, suggesting that the overproduction of cytokines during inflammation may be responsible. In in vitro culture experiments of human lymphoid cell (CEM) and human PBMC, IL-7, and IL-18 increased hGRbeta mRNA expression in these cells but GC itself did not. Through these analyses, it is indicated that the inflammatory cytokines altered the splicing condition of the primary transcript of hGR gene in IBD patients.
我们之前曾报道,在外周血单个核细胞(PBMC)中,作为糖皮质激素作用的一种假定的显性负调控因子,人糖皮质激素受体β亚型(hGRβ)的表达增强与溃疡性结肠炎(UC)患者对糖皮质激素(GC)无反应相关。在本研究中,我们通过实时荧光监测PCR对炎症性肠病(IBD)患者PBMC中hGR转录本的水平及系列变化进行了定量分析。结果显示,UC活动期的相对hGRβ mRNA表达显著高于UC非活动期或克罗恩病(CD)患者。纵向分析表明,UC患者炎症复发后hGRβ mRNA表达增加,提示炎症期间细胞因子的过度产生可能与此有关。在人淋巴细胞(CEM)和人PBMC的体外培养实验中,白细胞介素-7(IL-7)和白细胞介素-18(IL-18)可增加这些细胞中hGRβ mRNA的表达,但GC本身并无此作用。通过这些分析表明,炎症细胞因子改变了IBD患者hGR基因初级转录本的剪接状况。